Stephen P Juraschek1, Lara C Kovell2, Lawrence J Appel3, Edgar R Miller3, Frank M Sacks4, Alex R Chang5, Robert H Christenson6, Heather Rebuck6, Kenneth J Mukamal7. 1. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: sjurasch@bidmc.harvard.edu. 2. Division of Cardiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA. 3. The Johns Hopkins University School of Medicine, The Johns Hopkins Bloomberg School of Public Health, and The Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland, USA. 4. Harvard T.H. Chan School of Public Health, Harvard Medical School, Brigham & Women's Hospital, Boston, Massachusetts, USA. 5. Geisinger Health, Danville, Pennsylvania, USA. 6. Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA. 7. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
BACKGROUND: The DASH (Dietary Approaches to Stop Hypertension) diet has been determined to have beneficial effects on cardiac biomarkers. The effects of sodium reduction on cardiac biomarkers, alone or combined with the DASH diet, are unknown. OBJECTIVES: The purpose of this study was to determine the effects of sodium reduction and the DASH diet, alone or combined, on biomarkers of cardiac injury, strain, and inflammation. METHODS: DASH-Sodium was a controlled feeding study in adults with systolic blood pressure (BP) 120 to 159 mm Hg and diastolic BP 80 to 95 mm Hg, randomly assigned to the DASH diet or a control diet. On their assigned diet, participants consumed each of three sodium levels for 4 weeks. Body weight was kept constant. At the 2,100 kcal level, the 3 sodium levels were low (50 mmol/day), medium (100 mmol/day), and high (150 mmol/day). Outcomes were 3 cardiac biomarkers: high-sensitivity cardiac troponin I (hs-cTnI) (measure of cardiac injury), N-terminal pro-B-type natriuretic peptide (NT-proBNP) (measure of strain), and high-sensitivity C-reactive protein (hs-CRP) (measure of inflammation), collected at baseline and at the end of each feeding period. RESULTS: Of the original 412 participants, the mean age was 48 years; 56% were women, and 56% were Black. Mean baseline systolic/diastolic BP was 135/86 mm Hg. DASH (vs. control) reduced hs-cTnI by 18% (95% confidence interval [CI]: -27% to -7%) and hs-CRP by 13% (95% CI: -24% to -1%), but not NT-proBNP. In contrast, lowering sodium from high to low levels reduced NT-proBNP independently of diet (19%; 95% CI: -24% to -14%), but did not alter hs-cTnI and mildly increased hs-CRP (9%; 95% CI: 0.4% to 18%). Combining DASH with sodium reduction lowered hs-cTnI by 20% (95% CI: -31% to -7%) and NT-proBNP by 23% (95% CI: -32% to -12%), whereas hs-CRP was not significantly changed (-7%; 95% CI: -22% to 9%) compared with the high sodium-control diet. CONCLUSIONS: Combining a DASH dietary pattern with sodium reduction can lower 2 distinct mechanisms of subclinical cardiac damage: injury and strain, whereas DASH alone reduced inflammation. (Dietary Patterns, Sodium Intake and Blood Pressure [DASH - Sodium]; NCT00000608).
BACKGROUND: The DASH (Dietary Approaches to Stop Hypertension) diet has been determined to have beneficial effects on cardiac biomarkers. The effects of sodium reduction on cardiac biomarkers, alone or combined with the DASH diet, are unknown. OBJECTIVES: The purpose of this study was to determine the effects of sodium reduction and the DASH diet, alone or combined, on biomarkers of cardiac injury, strain, and inflammation. METHODS: DASH-Sodium was a controlled feeding study in adults with systolic blood pressure (BP) 120 to 159 mm Hg and diastolic BP 80 to 95 mm Hg, randomly assigned to the DASH diet or a control diet. On their assigned diet, participants consumed each of three sodium levels for 4 weeks. Body weight was kept constant. At the 2,100 kcal level, the 3 sodium levels were low (50 mmol/day), medium (100 mmol/day), and high (150 mmol/day). Outcomes were 3 cardiac biomarkers: high-sensitivity cardiac troponin I (hs-cTnI) (measure of cardiac injury), N-terminal pro-B-type natriuretic peptide (NT-proBNP) (measure of strain), and high-sensitivity C-reactive protein (hs-CRP) (measure of inflammation), collected at baseline and at the end of each feeding period. RESULTS: Of the original 412 participants, the mean age was 48 years; 56% were women, and 56% were Black. Mean baseline systolic/diastolic BP was 135/86 mm Hg. DASH (vs. control) reduced hs-cTnI by 18% (95% confidence interval [CI]: -27% to -7%) and hs-CRP by 13% (95% CI: -24% to -1%), but not NT-proBNP. In contrast, lowering sodium from high to low levels reduced NT-proBNP independently of diet (19%; 95% CI: -24% to -14%), but did not alter hs-cTnI and mildly increased hs-CRP (9%; 95% CI: 0.4% to 18%). Combining DASH with sodium reduction lowered hs-cTnI by 20% (95% CI: -31% to -7%) and NT-proBNP by 23% (95% CI: -32% to -12%), whereas hs-CRP was not significantly changed (-7%; 95% CI: -22% to 9%) compared with the high sodium-control diet. CONCLUSIONS: Combining a DASH dietary pattern with sodium reduction can lower 2 distinct mechanisms of subclinical cardiac damage: injury and strain, whereas DASH alone reduced inflammation. (Dietary Patterns, Sodium Intake and Blood Pressure [DASH - Sodium]; NCT00000608).
Authors: Jonathan Rubin; Kunihiro Matsushita; Christie M Ballantyne; Ron Hoogeveen; Josef Coresh; Elizabeth Selvin Journal: J Am Coll Cardiol Date: 2012-01-31 Impact factor: 24.094
Authors: Eloisa Colin-Ramirez; Finlay A McAlister; Yinggan Zheng; Sangita Sharma; Paul W Armstrong; Justin A Ezekowitz Journal: Am Heart J Date: 2014-11-20 Impact factor: 4.749
Authors: Christina M Parrinello; Pamela L Lutsey; Christie M Ballantyne; Aaron R Folsom; James S Pankow; Elizabeth Selvin Journal: Am Heart J Date: 2015-04-18 Impact factor: 4.749
Authors: Emelia J Benjamin; Salim S Virani; Clifton W Callaway; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Stephanie E Chiuve; Mary Cushman; Francesca N Delling; Rajat Deo; Sarah D de Ferranti; Jane F Ferguson; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Pamela L Lutsey; Jason S Mackey; David B Matchar; Kunihiro Matsushita; Michael E Mussolino; Khurram Nasir; Martin O'Flaherty; Latha P Palaniappan; Ambarish Pandey; Dilip K Pandey; Mathew J Reeves; Matthew D Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Uchechukwu K A Sampson; Gary M Satou; Svati H Shah; Nicole L Spartano; David L Tirschwell; Connie W Tsao; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner Journal: Circulation Date: 2018-01-31 Impact factor: 29.690
Authors: E Obarzanek; F M Sacks; W M Vollmer; G A Bray; E R Miller; P H Lin; N M Karanja; M M Most-Windhauser; T J Moore; J F Swain; C W Bales; M A Proschan Journal: Am J Clin Nutr Date: 2001-07 Impact factor: 7.045
Authors: Edna R Nakandakare; Ana M Charf; Flávia C Santos; Valéria S Nunes; Katia Ortega; Ana M P Lottenberg; Décio Mion; Takamitsu Nakano; Katsuyuki Nakajima; Elbio A D'Amico; Sergio Catanozi; Marisa Passarelli; Eder C R Quintão Journal: Atherosclerosis Date: 2008-02-11 Impact factor: 5.162
Authors: Ayman Samman Tahhan; Pratik Sandesara; Salim S Hayek; Muhammad Hammadah; Ayman Alkhoder; Heval M Kelli; Matthew Topel; Wesley T O'Neal; Nima Ghasemzadeh; Yi-An Ko; Mohamad Mazen Gafeer; Naser Abdelhadi; Fahad Choudhary; Keyur Patel; Agim Beshiri; Gillian Murtagh; Jonathan Kim; Peter Wilson; Leslee Shaw; Viola Vaccarino; Stephen E Epstein; Laurence Sperling; Arshed A Quyyumi Journal: J Am Heart Assoc Date: 2018-02-21 Impact factor: 5.501
Authors: Carlos Lahoz; Elisa Castillo; Jose M Mostaza; Olaya de Dios; Miguel A Salinero-Fort; Teresa González-Alegre; Francisca García-Iglesias; Eva Estirado; Fernando Laguna; Vanesa Sanchez; Concesa Sabín; Silvia López; Victor Cornejo; Carmen de Burgos; Carmen Garcés Journal: Nutrients Date: 2018-03-20 Impact factor: 5.717
Authors: Dana Haimovitz; Michelle Vereb; Lisa Freeman; Robert Goldberg; Darleen Lessard; John Rush; Darcy Adin Journal: J Vet Intern Med Date: 2022-04-14 Impact factor: 3.175
Authors: Ruth-Alma Turkson-Ocran; Kathryn Foti; Anika L Hines; Debora Kamin Mukaz; Hyunju Kim; Samantha Martin; Anum Minhas; Faye L Norby; Oluwabunmi Ogungbe; Alexander C Razavi; Mary R Rooney; Elisabeth L P Sattler; Jewel Scott; Alvin G Thomas; Curtis Tilves; Amelia S Wallace; Frances M Wang; Mingyu Zhang; Pamela L Lutsey; Kristie J Lancaster Journal: J Am Heart Assoc Date: 2022-02-18 Impact factor: 6.106